drugset / Trial / NCT02550977

Russia/Ukraine Suppression of Ovarian Activity Study

NCT02550977

Phase 2 Completed 91 enrolled Bayer
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to look into the effectiveness of a new investigational medication applied as a transdermal patch. The patch is applied on the skin with study medication that is absorbed through the skin suppressing ovarian activity and therefore preventing an egg from leaving an ovary (ovulation). The study will look into the study drug's safety and how well it is tolerated and its absorption, breakdown and elimination in the body. It describes how the body affects a specific drug after administration.

Timeline

Start
2015-09-18
Primary completion
2016-07-15
Completion
2016-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Gestodene Small molecule 2.1 mg Other
Subject ethinyl estradiol Small molecule 0.55 mg Other

Indications

No indication recorded.